Back to Articles

Manufacturing of CD19/CD20 Bispecific CAR-T Cell Therapy (IMPT-514) for the Treatment of Systemic Lupus Erythematosus

pipeline background

Chen X, et al. Poster presentation at the 8th Annual CAR-TCR Summit in Boston. August 2023

Connect with us on LinkedIn, or get in touch via email.

Linkedin-in Envelope
Menu
Contact

8501 Fallbrook Avenue, Suite 200

West Hills, CA 91304 USA

info@immpact-bio.com

(818) 857-4828

You are about to leave Immpact Bio's website to an external website.

Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.

You are about to leave Immpact Bio's website to an external website.

Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.

You are about to leave Immpact Bio's website to an external website.

Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.

You are about to leave Immpact Bio's website to an external website.

Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.

ImmPACT Bio is now part of Lyell Immunopharma

Learn More

If you have a question about a clinical trial, please contact us at info@immpact-bio.com